Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web...

Area of Science:

• Immunology
• Digital Health
• Allergy Research

Background:

• Allergen immunotherapy (AIT) is crucial for allergic rhinitis and asthma, targeting type 2 inflammation.
• Patient-centered care (PCC) strategies are vital for improving treatment engagement.
• Sublingual immunotherapy (SLIT) adherence is often challenging.

Purpose of the Study:

• To evaluate the efficacy of the AllergyVax® mobile application in enhancing patient adherence to SLIT.
• To assess the impact of a digital tool on patient engagement and treatment outcomes in respiratory allergic diseases.
• To determine if a patient-centered digital approach improves SLIT completion rates.

Main Methods:

• Retrospective cross-sectional analysis of 482 patients undergoing SLIT for respiratory allergies.
• Comparison between a group using the AllergyVax® app (Group B) and a control group receiving standard information (Group A).
• The app provided reminders, symptom questionnaires, and facilitated patient-provider communication.

Main Results:

• SLIT adherence was significantly higher in the app group (92.11%) compared to the non-app group (46.32%).
• App users were 2.42 times more likely to maintain adherence and experienced an 82% reduction in dropout rates.
• The AllergyVax® app demonstrated consistent adherence improvement across diverse demographic groups.

Conclusions:

• Mobile applications like AllergyVax® are effective in promoting adherence to SLIT for allergic diseases.
• Integrating digital solutions into AIT enhances patient engagement and improves overall treatment outcomes.
• Innovative digital tools play a critical role in managing allergic diseases and supporting long-term patient adherence.